Abstract: The present invention relates to a peptide with anti-inflammatory activity, wherein the peptide comprises any one amino acid sequence of SEQ ID NO: 1 to SEQ ID NO: 161, the peptide has above 80% homology of amino acid sequence with above-mentioned sequences, or the peptide is the fragment of the above-mentioned peptides. The present invention also relates to an inflammatory composition comprising the above mentioned peptides. According to the present invention, a peptide that has at least one amino acid sequence of SEQ ID NO: 1 to SEQ ID NO: 161 has outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising the peptides of this invention can be used as anti-inflammatory pharmaceutical compositions or as cosmetic compositions, in turn, treating and preventing a variety of different types of inflammatory diseases.

Abstract: The present invention relates to a peptide with anti-inflammatory activity, wherein the peptide comprises SEQ ID NO: 1, the peptide has above 80% homology of amino acid sequence with above-mentioned sequence, or the peptide is the fragment of the above-mentioned peptides. The present invention also relates to an inflammatory composition comprising the above mentioned peptides. According to the present invention, a peptide comprising a sequence of SEQ ID NO: 1 has an outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising the peptide of this invention can be used as anti-inflammatory pharmaceutical composition or as cosmetic composition, in turn, treating and preventing a variety of different types of inflammatory diseases.

Abstract: The present invention provides an improved pharmaceutical composition for storage and administration comprising (a) a bispecific antibody construct comprising a first domain binding to a target cell surface antigen and a second domain binding to a second antigen, wherein the bispecific antibody construct is present at a concentration in the range from about 0.5 ?g/ml to 20 mg/ml, (b) a preservative at a concentration effective to inhibit the growth of microbes, and (c) a diluent wherein bispecific antibody construct is stable and recoverable.

Abstract: The disclosure relates to a 5th generation (5G) or pre-5G communication system for supporting a data transmission rate higher than that of a 4th generation (4G) communication system such as long term evolution (LTE). An electronic device including an antenna in a wireless communication system is provided. The electronic device includes a radiator, a body, and a feeding circuit for transmitting a signal, wherein the radiator is coupled to at least a part of the body, the feeding circuit is coupled to the body to support the body, and the radiator is disposed to be spaced apart from the feeding circuit to form an air gap.

Abstract: A pixel and a display device including the pixel are disclosed. The pixel comprises a first transistor, a second transistor, a third transistor, a fourth transistor, a fifth transistor, a sixth transistor, a seventh transistor, an eighth transistor, a first capacitor, and a light emitting element. The eighth transistor includes a gate electrode configured to receive a second data voltage, a first electrode connected to a fourth node, and a second electrode configured to receive an initialization voltage. The eighth transistor adjusts a voltage level of the first capacitor based on a difference between the voltage level of the first capacitor and a level of the second data voltage.

Abstract: A pixel and a display device including the pixel are disclosed. The pixel comprises a first transistor, a second transistor, a third transistor, a fourth transistor, a fifth transistor, a sixth transistor, a seventh transistor, an eighth transistor, a first capacitor, and a light emitting element. The eighth transistor includes a gate electrode configured to receive a second data voltage, a first electrode connected to a fourth node, and a second electrode configured to receive an initialization voltage. The eighth transistor adjusts a voltage level of the first capacitor based on a difference between the voltage level of the first capacitor and a level of the second data voltage.

Abstract: The present disclosure provides a low pH pharmaceutical composition comprising (a) an antibody constructs comprising a first domain binding to a target cell surface antigen, a second domain binding to a second antigen and preferably a third domain, which is a specific Fc modality, (b) at least one buffer agent, (c) at least one saccharide, and (d) at least one surfactant; and wherein the pH of the pharmaceutical composition is in the range of 3.5 to 6.

Abstract: The present invention provides an improved pharmaceutical composition for storage and administration comprising (a) a bispecific antibody construct comprising a first domain binding to a target cell surface antigen and a second domain binding to a second antigen, wherein the bispecific antibody construct is present at a concentration in the range from about 0.5 ?g/ml to 20 mg/ml, (b) a preservative at a concentration effective to inhibit the growth of microbes, and (c) a diluent wherein bispecific antibody construct is stable and recoverable.

Abstract: An optical cable terminal box for distributing an optical cable with a plurality of cores to subscriber lines is provided. The optical cable terminal box may include a housing having a slot, the slot having a first receiving groove formed at an edge of the slot. The optical cable terminal box may also include a cover member coupled to the housing to close the slot, and the cover member may have a second receiving groove formed at an edge of the cover member. When the cover member closes the slot, the first and second grooves may be coupled to each other to form a wiring hole that is configured to pass an optical cable therethrough.

Abstract: An optical cable terminal box for distributing an optical cable with a plurality of cores to subscriber lines is provided. The optical cable terminal box may include a housing having a slot, the slot having a first receiving groove formed at an edge of the slot. The optical cable terminal box may also include a cover member coupled to the housing to close the slot, and the cover member may have a second receiving groove formed at an edge of the cover member. When the cover member closes the slot, the first and second grooves may be coupled to each other to form a wiring hole that is configured to pass an optical cable therethrough.